Efficacy of Antimicrobial Silver‐Plated Dressings Compared to Usual Care in Preventing Left Ventricular Assist Device Driveline Infections
Open Access
- 5 August 2026
- journal article
- Published by Wiley in Artificial Organs
- Vol. 50 (11) , 1644-1651
Abstract
Background: Left ventricular assist device (LVAD) driveline infections (DLIs) represent one of the most common adverse events in LVAD patients. This study investigates the effectiveness of a silver‐plated antimicrobial dressing (Silverlon, Bravida Medical) in addition to usual driveline wound care for DLI‐prevention. The primary outcome was six‐months freedom from DLI. Secondary outcomes included independent risk factors for DLI, freedom from DLI‐related hospital readmission, freedom from negative pressure wound therapy (NPWT) and temporal changes in DESTINE wound staging. Methods: This single center cohort study included 61 patients implanted with a HeartMate 3 LVAD between 2022 and 2025 (8.2% female; median age 61 (55; 67 IQR) years; BMI 27.2 (±4.42 STD) kg/m 2 ). Starting with the first follow‐up visit (FFUV) after hospital discharge, 39 patients received usual wound care, while 22 patients additionally received Silverlon. Results: The Silverlon group demonstrated a significantly greater freedom from DLI (100% vs. 71.8%; p = 0.017). No independent predictors of DLI were identified due to the complete absence of DLIs in the Silverlon group (0 vs. 11 events); multivariable Cox regression effect could not be mathematically estimated. The Silverlon group showed 100% freedom from DLI‐related readmission and NPWT therapy (vs. 97.4%; p = 0.45). DESTINE stages 0–1 predominated within the Silverlon group; severe stages (3, 4) occurred exclusively within the usual care group ( p > 0.22). Conclusion: Given the substantial burden of DLI, integrating silver‐plated wound dressings into standard LVAD wound care appears to be a safe and effective strategy, associated with enhanced wound healing and a reduction in DLI incidence.Keywords
This publication has 29 references indexed in Scilit:
- Net prolongation of life in advanced heart failure: An intentional strategy of durable LVAD therapy followed by heart transplantationThe Journal of Heart and Lung Transplantation, 2026
- The Society of Thoracic Surgeons Intermacs 2025 Annual Report: Focus on Outcomes in Older AdultsThe Annals of Thoracic Surgery, 2025
- Heterogeneity in HeartMate 3 implanting center infection management reveals opportunities for quality improvement and best practice initiatives during left ventricular assist device supportThe Journal of Heart and Lung Transplantation, 2025
- Defining optimal left ventricular assist device short-term outcomes may provide insight into programmatic quality assessmentThe Journal of Heart and Lung Transplantation, 2024
- The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devicesThe Journal of Heart and Lung Transplantation, 2024
- Economic Evaluation of Quality Improvement Interventions Designed to Prevent Hospital ReadmissionJAMA Internal Medicine, 2017
- Preventability and Causes of Readmissions in a National Cohort of General Medicine PatientsJAMA Internal Medicine, 2016
- Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infectionsThe Journal of Heart and Lung Transplantation, 2016
- Silver-based dressings for the reduction of surgical site infection: Review of current experience and recommendation for future studiesBurns, 2014
- Silver in medicine: A brief history BC 335 to presentBurns, 2014